Gemma Gatta

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi request reprint Childhood cancer survival trends in Europe: a EUROCARE Working Group study
    Gemma Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy
    J Clin Oncol 23:3742-51. 2005
  2. doi request reprint Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Acta Oncol 49:776-83. 2010
  3. doi request reprint The burden of rare cancers in Europe
    Gemma Gatta
    Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
    Adv Exp Med Biol 686:285-303. 2010
  4. doi request reprint Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milano, Italy Electronic address
    Lancet Oncol 15:35-47. 2014
  5. doi request reprint Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization
    Gemma Gatta
    Evaluative Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    J Natl Cancer Inst Monogr 2013:79-87. 2013
  6. doi request reprint Cancer prevalence estimates in Europe at the beginning of 2000
    G Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Oncol 24:1660-6. 2013
  7. pmc Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
    Haematologica 98:744-52. 2013
  8. doi request reprint Embryonal cancers in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:1425-33. 2012
  9. doi request reprint Survival for ethmoid sinus adenocarcinoma in European populations
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, Milan, Italy
    Acta Oncol 48:992-8. 2009
  10. doi request reprint Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study
    Gemma Gatta
    Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy
    J Cancer Surviv 1:247-54. 2007

Detail Information

Publications44

  1. ncbi request reprint Childhood cancer survival trends in Europe: a EUROCARE Working Group study
    Gemma Gatta
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy
    J Clin Oncol 23:3742-51. 2005
    ..EUROCARE collected data from population-based cancer registries in 20 European countries. We used this data to compare childhood cancer survival time trends in Europe...
  2. doi request reprint Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Acta Oncol 49:776-83. 2010
    ....
  3. doi request reprint The burden of rare cancers in Europe
    Gemma Gatta
    Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
    Adv Exp Med Biol 686:285-303. 2010
    ..The burden indicators were estimated and are provided in this chapter...
  4. doi request reprint Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milano, Italy Electronic address
    Lancet Oncol 15:35-47. 2014
    ..The EUROCARE-5 survival study estimates survival of children diagnosed with cancer between 2000 and 2007, assesses whether survival differences among European countries have changed, and investigates changes from 1999 to 2007...
  5. doi request reprint Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization
    Gemma Gatta
    Evaluative Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    J Natl Cancer Inst Monogr 2013:79-87. 2013
    ..The treatments given for major cancers also varied; advanced stage at diagnosis was associated with poor 5-year relative survival and low odds of receiving standard treatment for breast and colorectal cancer. ..
  6. doi request reprint Cancer prevalence estimates in Europe at the beginning of 2000
    G Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Oncol 24:1660-6. 2013
    ..This paper provides prevalence estimates for 16 major cancers in Europe at the beginning of the year 2003...
  7. pmc Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
    Haematologica 98:744-52. 2013
    ..Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries...
  8. doi request reprint Embryonal cancers in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:1425-33. 2012
    ..Survival/cure rate is generally high, but there are considerable gaps in our understanding of the natural histories of these rare diseases particularly in adults...
  9. doi request reprint Survival for ethmoid sinus adenocarcinoma in European populations
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, Milan, Italy
    Acta Oncol 48:992-8. 2009
    ..Adenocarcinoma of the ethmoid sinus is rare. EUROCARE data provide a good opportunity to study the survival of this rare disease in a population of continental size...
  10. doi request reprint Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study
    Gemma Gatta
    Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy
    J Cancer Surviv 1:247-54. 2007
    ....
  11. doi request reprint Prostate cancer treatment in Europe at the end of 1990s
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy
    Acta Oncol 48:867-73. 2009
    ..We therefore aimed to characterize treatment for prostate cancer across Europe...
  12. doi request reprint Rare cancers are not so rare: the rare cancer burden in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 47:2493-511. 2011
    ..The project Surveillance of Rare Cancers in Europe (RARECARE) provides estimates of the incidence, prevalence and survival of rare cancers in Europe based on a new and comprehensive list of these diseases...
  13. ncbi request reprint Survival from rare cancer in adults: a population-based study
    Gemma Gatta
    Epidemiology Unit, National Cancer Institute, Milan, Italy
    Lancet Oncol 7:132-40. 2006
    ..We aimed to study the epidemiology of rare cancers in a large population of several countries...
  14. doi request reprint Rectal cancer
    Maria Giulia Zampino
    Medical Care Unit, European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 70:160-82. 2009
    ..Updated recommendations for the management of these patients are here reported...
  15. doi request reprint Survival of European children and young adults with cancer diagnosed 1995-2002
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
    Eur J Cancer 45:992-1005. 2009
    ..Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe...
  16. doi request reprint The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project
    Annalisa Trama
    Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Tumori 98:550-8. 2012
    ....
  17. doi request reprint Human papillomavirus in HNSCC: a European epidemiologic perspective
    Lisa Licitra
    Head and Neck Medical Oncology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Hematol Oncol Clin North Am 22:1143-53, vii-viii. 2008
    ..Three-year survival rates improved more in human papillomavirus-related than unrelated cancer sites, and women had better rates of survival than men...
  18. doi request reprint Survival from salivary glands adenoid cystic carcinoma in European populations
    Laura Ciccolallo
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Oral Oncol 45:669-74. 2009
    ..Improvements in the disease detection in its early stage and international collaborative research should be encouraged...
  19. doi request reprint Major and minor salivary gland tumors
    Marco Guzzo
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 74:134-48. 2010
    ..Metastatic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases. For highly selected patients the employment of anti-androgen therapy is indicated...
  20. ncbi request reprint Childhood cancer survival in Europe and the United States
    Gemma Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 95:1767-72. 2002
    ..The objective of this study was to determine whether transatlantic differences in survival also are present in childhood cancers...
  21. ncbi request reprint Ependymoma
    Michele Reni
    Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy
    Crit Rev Oncol Hematol 63:81-9. 2007
    ..There is no proof that postoperative chemotherapy improves the outcome. At recurrence, platinum-, nitrosourea- or temozolomide-based chemotherapy can be administered, although there is no evidence of efficacy...
  22. ncbi request reprint Rectal cancer
    Maria Giulia Zampino
    European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 51:121-43. 2004
    ..Updated recommendations for the management of these patients are here reported...
  23. ncbi request reprint [Case-control evaluation of screening efficacy]
    Franco Berrino
    Unità di epidemiologia eziologica e prevenzione, Dipartimento di medicina preventiva e predittiva, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano
    Epidemiol Prev 28:354-9. 2004
  24. doi request reprint Childhood medulloblastoma
    Maura Massimino
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 79:65-83. 2011
    ....
  25. ncbi request reprint Cancer of the larynx
    Lisa Licitra
    START Project, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 47:65-80. 2003
    ..The loco-regional extent of the disease determines the success of cure. Surgery and radiotherapy represent the main therapeutic options. The choice between these two procedures is often controversial...
  26. ncbi request reprint Ovarian cancer
    Nicoletta Colombo
    European Institute of Oncology, Division of Gynecology, Via Ripamonti 435, Milan, Italy
    Crit Rev Oncol Hematol 60:159-79. 2006
    ..Salvage chemotherapy in platinum-refractory patients usually results in low response rates and short survival...
  27. ncbi request reprint International collaborations in cancer control and the Third International Cancer Control Congress
    Andrea Micheli
    Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Tumori 95:579-96. 2009
    ..As a consequence, less resources of development aids are allocated to control NCDs including cancer...
  28. ncbi request reprint Cancer of the nasopharynx
    Lisa Licitra
    START Project and Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Crit Rev Oncol Hematol 45:199-213. 2003
    ..Standard therapeutic option for early stages of NPC is radiation, while an integration of radiation therapy and chemotherapy is indicated in more advanced stages...
  29. ncbi request reprint Cancer of pancreas
    Filippo De Braud
    START Project and European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 50:147-55. 2004
    ..Radical surgery is indicated for patients with early stage of disease, mainly stage I and partially II. In all other cases, the aim of treatment is the palliation of different very distressing symptoms related to this neoplasm...
  30. ncbi request reprint Incidence of uveal melanoma in Europe
    Gianni Virgili
    Department of Ophthalmology, University of Florence, Florence, Italy
    Ophthalmology 114:2309-15. 2007
    ..To estimate incidence rates of uveal melanoma in Europe from 1983 to 1994...
  31. ncbi request reprint Explaining gastric cancer survival differences among European countries
    Arduino Verdecchia
    Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161 Rome, Italy
    Int J Cancer 109:737-41. 2004
    ..There is a need to improve completeness and standardization of detailed information collected on gastric cancer patients to allow detailed comparative analyses and interpretation...
  32. ncbi request reprint Regional estimates of prostate cancer burden in Italy
    Riccardo Inghelmann
    Reparto di Epidemiologia dei Tumori, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanita, Rome, Italy
    Tumori 93:380-6. 2007
    ....
  33. doi request reprint Survival in patients with uveal melanoma in Europe
    Gianni Virgili
    Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Viale Morgagni 85, Florence 50134, Italy
    Arch Ophthalmol 126:1413-8. 2008
    ..To estimate survival in patients in whom uveal melanoma was diagnosed between January 1, 1983, and December 31, 1994, in Europe...
  34. ncbi request reprint Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study
    Emmanuel Mitry
    Service d Hépatogastroentérologie et Oncologie Digestive, Centre Hospitalo Universitaire Ambroise Paré, AP HP, Faculté de Médecine Paris Ile de France Ouest et Université Versailles Saint Quentin, 92100 Boulogne, France
    Eur J Cancer 42:2363-8. 2006
    ..This may, at least partly, be explained by the rarity of this diagnosis. Prognosis may be improved by the use of specific treatment guidelines for nephroblastoma in adults...
  35. ncbi request reprint Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
    Arduino Verdecchia
    National Centre for Epidemiology, Health Surveillance and Promotion, Istituto Superiore di Sanita, Rome, Italy
    Lancet Oncol 8:784-96. 2007
    ..We also compared our findings with data on cancer survival in the USA from the US SEER (Surveillance, Epidemiology, and End Results) programme...
  36. doi request reprint Cancer survival in five continents: a worldwide population-based study (CONCORD)
    Michel P Coleman
    Cancer Research UK Cancer Survival Group, Non communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
    Lancet Oncol 9:730-56. 2008
    ..This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets...
  37. doi request reprint Oligodendroglioma
    Martin J van den Bent
    Daniel den Hoed Cancer Clinic Erasmus University Medical Center, Rotterdam, The Netherlands
    Crit Rev Oncol Hematol 66:262-72. 2008
    ..Adjuvant PCV chemotherapy increased progression-free survival but does not improve survival as compared to PCV given at recurrence. Chemotherapy with either PCV or temozolomide constitutes a standard for recurrent/progressive disease...
  38. ncbi request reprint Renal cancer
    Enrichetta Corgna
    Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
    Crit Rev Oncol Hematol 64:247-62. 2007
    ..Biologic agents represent the major effective therapies for widespread metastatic renal cancer. An antiangiogenic strategy, the neutralization of VEGF, can slow the growth rate of advanced cancer...
  39. ncbi request reprint Cancer of the prostate
    Sergio Bracarda
    Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
    Crit Rev Oncol Hematol 56:379-96. 2005
    ..5 months) and quality of life with docetaxel in more than 1,600 cases...
  40. ncbi request reprint Adult acute lymphoblastic leukaemia
    Renato Bassan
    Ospedali Riuniti, Bergamo, Italy
    Crit Rev Oncol Hematol 50:223-61. 2004
    ..Therapeutic progress may be obtainable through a careful integration of chemotherapy, stem cell transplantation, and the new targeted treatments with highly specific metabolic inhibitors and humanised monoclonal antibodies...
  41. doi request reprint Glioblastoma in adults
    Alba A Brandes
    Department of Medical Oncology, Bellaria Maggiore Hospital, Azienda ASL, Bologna, Italy
    Crit Rev Oncol Hematol 67:139-52. 2008
    ..At time of recurrence/progression, a nitrosourea-based chemotherapy constitutes a reasonable option, as well as a temozolomide re-challenge for patients without progression during prior temozolomide treatment...
  42. ncbi request reprint Anaplastic astrocytoma in adults
    Roger Stupp
    University Hospital CHUV, Lausanne, Switzerland
    Crit Rev Oncol Hematol 63:72-80. 2007
    ..In recurrent disease, chemotherapy with temozolomide has been proven to be active and well-tolerated in phase II trials, but no comparative phase III trials of other cytotoxic drugs have been conducted...
  43. ncbi request reprint Colon cancer
    Roberto Labianca
    Ospedali Riuniti, Bergamo, Italy
    Crit Rev Oncol Hematol 51:145-70. 2004
    ..This report summarizes the most important achievements in this field and provides the readers useful suggestions for their professional practice...
  44. ncbi request reprint Adult acute myeloid leukaemia
    Matthew Smith
    St Bartholomew s Hospital, London, UK
    Crit Rev Oncol Hematol 50:197-222. 2004
    ....